NeuroSAFE Trial Enhances Post-Surgery Sexual Function

The NeuroSAFE surgical technique significantly enhances the preservation of erectile function in prostate cancer patients compared to traditional surgery, as demonstrated by the NeuroSAFE PROOF trial presented at the 2025 European Association of Urology Congress. This robot-assisted method preserves neurovascular bundles critical for erections and urinary continence, with the trial showing nearly twice as many men retaining erectile function post-surgery. The procedure includes a real-time examination of the prostate tissue during surgery to ensure complete cancer removal without compromising nerve preservation. This innovative approach, which leverages robotic precision, aims to improve the quality of life for prostate cancer patients by reducing common side effects like erectile dysfunction and urinary incontinence. Prostate cancer remains a leading health concern for men, particularly those over 50, and advancements like NeuroSAFE could encourage more men to undergo early screening and intervention.